disease 1,489 words KG: ent-dise-f4fe1a7d 2026-03-21
kind:diseasesection:diseasesstate:published
Contents

DRPLA (Dentatorubral-Pallidoluysian Atrophy)

Disease Info
Atrophin-1 protein accumulationIntranuclear inclusions containing mutant ATN1 protein with expanded polyQ tracts, most abundant in neurons of the striatum and cerebellum
White matter degenerationInvolvement of cerebellar white matter and pontocerebellar tracts
Cerebral atrophyProgressive cortical and subcortical brain atrophy, particularly in later stages 9
Dentate nucleus and red nucleusDegeneration underlies progressive cerebellar ataxia
Globus pallidus (external segment)Choreoathetosis and dystonia
Subthalamic nucleusMovement disorder manifestations
BrainstemVarious neurological symptoms including dysphagia and dysarthria 10
Progressive myoclonus epilepsy (PME)Intractable myoclonic seizures, often with generalized tonic-clonic seizures
Severe intellectual disabilityProgressive cognitive decline leading to profound dementia
MyoclonusLess prominent than in juvenile form
AtaxiaProgressive cerebellar ataxia with gait instability
Chorea and athetosisInvoluntary choreiform movements, often beginning in the face and extremities
DatabasesOMIMOrphanetClinicalTrialsPubMed

Knowledge Graph

Related Hypotheses (1)

Trinucleotide Repeat Sequestration via CRISPR-Guided RNA Tar
Score: 0.48

Related Analyses (3)

Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · archived
Protein aggregation cross-seeding across neurodegenerative d
neurodegeneration · archived
Metabolic reprogramming in neurodegenerative disease
neurodegeneration · completed

Related Experiments (13)

Animal Model Comparison for Neurodegenerative Disease Therap
clinical · proposed · Score: 0.40
Endocannabinoid System Dysfunction Validation in Parkinson's
clinical · proposed · Score: 0.40
Glymphatic-Circadian Axis Enhancement Therapy for Parkinson'
clinical · proposed · Score: 0.40
Levodopa-Induced Dyskinesias Mechanism — Experiment Design
validation · proposed · Score: 0.40
Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propag
clinical · proposed · Score: 0.40